Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukaemia Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04648475
What this trial is testing

Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma

Who this might be right for
Leukemia, B-cellLymphoma, B-Cell
Chongqing Precision Biotech Co., Ltd 40
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00006475
What this trial is testing

STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis

Who this might be right for
Leukemia
Novartis
Early research (Phase 1)Study completedNCT01332786
What this trial is testing

Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University Health Network, Toronto 27
Large-scale testing (Phase 3)Looking for participantsNCT06387069
What this trial is testing

Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hutchmed 316
Testing effectiveness (Phase 2)Ended earlyNCT00006220
What this trial is testing

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Washington University School of Medicine 5
Early research (Phase 1)UnknownNCT04480788
What this trial is testing

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Who this might be right for
T Lymphoblastic Leukemia/LymphomaExtramedullary NK-T-cell Lymphoma, Nasal TypePeripheral T-cell Lymphoma, Nonspecific+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 9
Testing effectiveness (Phase 2)Ended earlyNCT01612988
What this trial is testing

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL

Who this might be right for
B-cell Chronic Lymphocytic Leukemia (B-CLL)
French Innovative Leukemia Organisation 74
Early research (Phase 1)Study completedNCT01732861
What this trial is testing

Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Who this might be right for
Leukemia Lymphocytic Chronic B-Cell
Celgene 20
Testing effectiveness (Phase 2)WithdrawnNCT02167360
What this trial is testing

Study of Efficacy and Safety of CTL019 in Adult ALL Patients

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Study completedNCT01497496
What this trial is testing

Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 29
Testing effectiveness (Phase 2)UnknownNCT05587088
What this trial is testing

Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)

Who this might be right for
Neoplasm, StomachGastric Neoplasms MalignantPancreatic Neoplasms+6 more
Hospital Universitario San Ignacio 82
Early research (Phase 1)Study completedNCT00874562
What this trial is testing

Rapamycin in Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 6
Testing effectiveness (Phase 2)Study completedNCT02061761
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Hematologic Neoplasms
Bristol-Myers Squibb 106
Early research (Phase 1)Looking for participantsNCT06696846
What this trial is testing

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory T-cell LymphomaRelapsed/Refractory Acute Myeloid Leukemia
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Early research (Phase 1)Not Yet RecruitingNCT06641024
What this trial is testing

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd 24
Not applicableUnknownNCT03964922
What this trial is testing

Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation

Who this might be right for
Relapse LeukemiaAllogeneic Stem Cell TransplantationImmune Evasion, Tumor
Central Hospital, Nancy, France 104
Testing effectiveness (Phase 2)WithdrawnNCT01162031
What this trial is testing

Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

Who this might be right for
LeukemiaAcute Lymphocytic Leukemia
Stanford University
Early research (Phase 1)Study completedNCT03848754
What this trial is testing

Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed Adult AML
Medical College of Wisconsin 14
Early research (Phase 1)WithdrawnNCT03347994
What this trial is testing

Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Justin Watts
Next Page